Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Fresenius Medical Care AG & Co KGaAFMS13.570.640.746.735.82%1.81%47.04$20.43$100.204,250$22.17

Detail of Fresenius Medical Care AG & Co KGaA

 
CEO
Ms. Helen Giza
Employees
113079
Industry
Medical Care Facilities
Sector
Healthcare
Market cap
$12B

Company details

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$19.24B
Cost of goods (CoG)
-$14.40B
Gross profit (GP)
$4.84B
Operating expense (OE)
-$3.12B
Research and development (R&D)
-$199.83M
General and administrative (G&A)
-$3.15B
Other (OTH)
$232.66M
Operating income (OI)
$1.72B
Other income expense (OIE)
-$158.91M
Pretax income (PI)
$1.22B
Tax (TAX)
-$341.50M
Net income (NI)
$879.90M
Fresenius Medical Care AG & Co KGaA
FMS • XNYS • US
$22.17
+1.04 (4.92%)
Stock vs Industry average
  • Industry average

Dividend yield
2.86%
Trailing annual dividend rate
$1.19
Payout ratio
52.76%
EPS
$1.63
Margin profit
3.42%
52 week low
$18.120001
52 week high
$22.41
50-day simple moving average
$21.70
200-day simple moving average
$20.43
Percent held by insiders
0.00%
Percent held by institutions
7.40%
Dividend yield
5.02%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
FMS +5.37%
eps change
FMS +151.72%